Amrutanjan Health Care · NSE: AMRUTANJAN · BSE: 590006
Q2 FY24 results · Jul–Sep 2023
Amrutanjan Health Care reported revenue from operations of ₹99.31 crore (down 10.3% from Q2 FY23) and net profit of ₹6.85 crore (down 46.3% from Q2 FY23) for Q2 FY24 (Jul–Sep 2023), on a standalone basis.
| Item | Q2 FY24 | Q2 FY23 | YoY | Q1 FY24 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 99.31 | 110.72 | −10.3% | 77.86 | +27.5% |
| Other income | 3.95 | 3.03 | +30.2% | 3.69 | +7.1% |
| Total income | 103.26 | 113.75 | −9.2% | 81.55 | +26.6% |
| Profit before tax | 9.21 | 17.42 | −47.2% | 9.43 | −2.4% |
| Net profit for the period | 6.85 | 12.77 | −46.3% | 7.01 | −2.4% |
| EPS, basic (₹) | 2.36 | 4.37 | −46.0% | 2.40 | −1.7% |
| Net margin (%) | 6.9 | 11.5 | 9.0 |
Standalone
- Filed with BSE
- 23 Nov 2023, 15:27 IST
- Board meeting
- 10 Nov 2023
- Period
- 01 Jul 2023 to 30 Sep 2023
- Review status
- Unaudited
- Source
- XBRL filing on BSE